Robert Carey
CIK 1602064 · EVP, Chief Business Officer · last filed 2025-11-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.06M
Companies
4
Total Filings
71
Lifetime Open-Market Net
$8.91M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XAIR | Director | 5,543,490 | $0.37 | $2.06M | $9.42M | 36 | 2025-11-07 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 99,600 | $0.18 | $17.7K | $0 | 11 | 2025-06-16 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP, Chief Business Officer | 266,358 | $116.30 | $30.98M | -$509.8K | 17 | 2019-03-25 |
| ARGOS THERAPEUTICS INC (ARGS) Delisted | Director | 8,206 | — | — | $0 | 6 | 2017-01-20 |
Recent Filings · Page 3 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-30 | XAIR | Buy (P) | +30,000 | $172.5K | EDGAR |
| 2022-11-18 | XAIR | Buy (P) | +50,000 | $294.0K | EDGAR |
| 2022-07-05 | XAIR | Buy (P) | +175,000 | $1.13M | EDGAR |
| 2022-04-06 | XAIR | Buy (P) | +20,000 | $134.2K | EDGAR |
| 2022-03-28 | XAIR | Buy (P) | +26,185 | $173.9K | EDGAR |
| 2022-03-21 | XAIR | Buy (P) | +20,000 | $135.0K | EDGAR |
| 2022-03-07 | XAIR | Grant (A) | — | $0 | EDGAR |
| 2022-03-01 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2021-12-27 | XAIR | Buy (P) | +10,000 | $95.0K | EDGAR |
| 2021-11-26 | XAIR | Buy (P) | +5,000 | $61.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.